ATHENIUM PHARMACEUTICALS, LLC

Serial Number 98166743
645

Registration Progress

Application Filed
Sep 6, 2023
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Final Refusal E-Mailed
Due: Sep 18, 2025 63 days

Trademark Image

ATHENIUM PHARMACEUTICALS, LLC

Basic Information

Serial Number
98166743
Filing Date
September 6, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
645
Status Date
Jun 18, 2025
Application
Pending
Classes
042

Rights Holder

Danco Investors Group, L.P.

13
Address
P. O. Box 150008
Nashville, TN 37215

Ownership History

Danco Investors Group, L.P.

Original Applicant
13
Nashville, TN

Legal Representation

Attorney
Robert L. Brewer

USPTO Deadlines

Next Deadline
63 days remaining
Final Refusal E-Mailed
Due Date
September 18, 2025
Extension Available
Until December 18, 2025

Application History

25 events
Date Code Type Description Documents
Jun 18, 2025 CNFR R FINAL REFUSAL WRITTEN Loading...
Jun 18, 2025 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jun 18, 2025 GNFR O FINAL REFUSAL E-MAILED Loading...
Jun 2, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 2, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 2, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 3, 2025 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Mar 3, 2025 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Feb 7, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 7, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 7, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 2, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 2, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 2, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 7, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 6, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 6, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 19, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Jul 19, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
May 6, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 6, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 6, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 1, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 28, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 9, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical services, namely, research and development services of new pharmaceutical products
First Use Anywhere: Mar 18, 2002
First Use in Commerce: Mar 18, 2002

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
PHARMACEUTICALS, LLC